MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ORMP has $268,847K in assets. $13,202K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
645.18%
Quick Ratio
645.18%
Cash Ratio
124.98%
Unit: Thousand (K) dollars
Assets Breakdown
    • Total long-term assets
    • Total current assets
Liabilities Breakdown
    • Total equity
    • Total long-term liabilities
    • Total current liabilities

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
13,202 45,947 52,179 15,797
Short-term deposits
11,097 10,979 4,038 22,865
Marketable securities
4,965 5,417 4,956 1,753
Investments at fair value
36,576 63,551 73,514 57,525
Convertible note (note 9)
-4,636 --
Prepaid expenses and other current assets
2,310 2,741 1,430 1,086
Total current assets
68,150 133,271 136,117 99,026
Long-term deposits
2 2 2 2
Marketable securities
17,967 8,371 --
Investments at fair value
50,678 10,119 11,410 8,789
Investment in associate at fair value
102,299 71,623 64,803 44,298
Loan to an equity method investee
423 553 1,044 2,529
Investment in lifeward
22,492 ---
Investment in real estate (note 5)
-1,921 2,122 1,951
Investment in real estate
1,921 ---
Other non-marketable equity securities
3,624 3,624 3,524 3,524
Amounts funded in respect of employee rights upon retirement
46 44 40 38
Property and equipment, net
561 586 614 645
Operating lease right-of-use assets
684 750 817 882
Total long-term assets
200,697 97,593 84,376 62,658
Total assets
268,847 230,864 220,493 161,684
Accounts payable and accrued expenses
8,521 6,201 4,861 2,159
Payable to related parties (note 20)
-652 1 34
Deferred income (note 8)
-1,353 986 1,236
Deferred income
1,471 ---
Dividend payable
303 10,595 --
Operating lease liabilities
268 285 271 264
Total current liabilities
10,563 19,086 6,119 3,693
Long-term deferred revenues (note 13)
-2,000 2,000 2,000
Long-term deferred income (note 8)
-1,269 1,496 1,724
Deferred income
1,530 ---
Other liabilities
---0
Employee rights upon retirement
40 39 38 36
Operating lease liabilities
493 540 589 648
Dividend payable
198 275 --
Deferred tax liabilities
17,747 7,911 7,921 -
Total long-term liabilities
20,008 12,034 12,044 4,408
Common stock, 0.012 par value (60,000,000 authorized shares 40,926,081 and 39,275,006 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively)
491 472 490 491
Additional paid-in capital
322,906 322,708 325,367 325,008
Accumulated deficit
-85,121 -123,436 -122,575 -170,970
Total stockholders equity
-199,744 203,282 154,529
Non-controlling interests
---952 -946
Total equity
238,276 199,744 202,330 153,583
Total liabilities and equity
268,847 230,864 220,493 161,684
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investment in associate atfair value$102,299K Investments at fair value$50,678K Investment in lifeward$22,492K Marketable securities$17,967K Other non-marketableequity securities$3,624K Investment in real estate$1,921K Operating leaseright-of-use assets$684K Property and equipment,net$561K Loan to an equitymethod investee$423K Amounts funded inrespect of employee...$46K Long-term deposits$2K Investments at fair value$36,576K Cash and cashequivalents$13,202K Short-term deposits$11,097K Marketable securities$4,965K Prepaid expenses andother current assets$2,310K Total long-termassets$200,697K Total current assets$68,150K Total assets$268,847K Total liabilities andequity$268,847K Total equity$238,276K Total long-termliabilities$20,008K Total currentliabilities$10,563K Accumulated deficit-$85,121K Additional paid-in capital$322,906K Deferred tax liabilities$17,747K Deferred income$1,530K Operating leaseliabilities$493K Dividend payable$198K Employee rights uponretirement$40K Accounts payable andaccrued expenses$8,521K Deferred income$1,471K Dividend payable$303K Operating leaseliabilities$268K Common stock, 0.012 parvalue (60,000,000...$491K

ORAMED PHARMACEUTICALS INC. (ORMP)

ORAMED PHARMACEUTICALS INC. (ORMP)